Business Standard

'The fraud at Satyam is an accident'

Q&A: C B Bhave

C B Bhave
Related News

The Securities and Exchange Board of India Chairman C B Bhave today said at a press meet that Raju’s letter was not enough to put him in front of a magistrate and that the regulator will file a case against Satyam only after the investigation was complete. He also said that there was a need to assure investors that this was a one-off case.

On barring Price Waterhouse from the audit business
The investigations are going on. It is not right to blame one party or the other. We had nothing on hand apart from Raju’s letter 48 hours ago. Though yesterday was a holiday, a Sebi team visited Hyderabad to inspect the books of the company. Today the company’s chief financial officer spoke to the inspection team. The team has asked for Raju’s presence to question him. There will be a meeting with Raju tomorrow. We must wait for more evidence to come out.

On Sebi co-ordinating with US regulator Securities and Exchange Commission (SEC) to investigate the fraud
We have not sent any Sebi official to the US since the case falls in the Indian jurisdiction. But there will be co-ordinated action from both the regulators. The company has made a filing with the US SEC. We have a memorandum of understanding (MoU) with the SEC where we share information with each other.

On filing a case against Satyam
Action can be taken against the company under the Companies Act. Action can be taken under the Sebi Act or the Indian Penal Code (IPC). The police can take cognisance of the issue.

Failure of Clause 49 that stipulates the appointment of independent directors
The fraud at Satyam is an accident. After each accident, we must thoroughly investigate the cause.

Read more on:   
|
|

'The fraud at Satyam is an accident'

Q&A: C B Bhave

The Securities and Exchange Board of India Chairman C B Bhave today said at a press meet that Raju’s letter was not enough to put him in front of a magistrate and that the regulator will file a

The Securities and Exchange Board of India Chairman C B Bhave today said at a press meet that Raju’s letter was not enough to put him in front of a magistrate and that the regulator will file a case against Satyam only after the investigation was complete. He also said that there was a need to assure investors that this was a one-off case.

On barring Price Waterhouse from the audit business
The investigations are going on. It is not right to blame one party or the other. We had nothing on hand apart from Raju’s letter 48 hours ago. Though yesterday was a holiday, a Sebi team visited Hyderabad to inspect the books of the company. Today the company’s chief financial officer spoke to the inspection team. The team has asked for Raju’s presence to question him. There will be a meeting with Raju tomorrow. We must wait for more evidence to come out.

On Sebi co-ordinating with US regulator Securities and Exchange Commission (SEC) to investigate the fraud
We have not sent any Sebi official to the US since the case falls in the Indian jurisdiction. But there will be co-ordinated action from both the regulators. The company has made a filing with the US SEC. We have a memorandum of understanding (MoU) with the SEC where we share information with each other.

On filing a case against Satyam
Action can be taken against the company under the Companies Act. Action can be taken under the Sebi Act or the Indian Penal Code (IPC). The police can take cognisance of the issue.

Failure of Clause 49 that stipulates the appointment of independent directors
The fraud at Satyam is an accident. After each accident, we must thoroughly investigate the cause.

image

Read More

Emerging markets should continue to drive global growth: Jyotivardhan Jaipuria

With the government stepping on the reform pedal and the Reserve Bank of India (RBI) likely to cut rates, we expect a mild recovery in both the ...

Recommended for you

Quick Links

Market News

Sensex ends down 242 points; IT shares drag

The 30-share Sensex provisionally ended down 242 points at 28,425 and the 50-share Nifty ended down 104 points at 8,603.

Pharma shares extend fall; CNX Pharma index down 3%

Lupin, Aurobindo, Sun Pharma, Cadila Healthcare, Venus Remedies, SPARC & Shasun Pharma down were 3%-7%.

CRISIL falls from record high on weak March quarter results

The stock down 8% to Rs 2,165 on the NSE after reporting 18% yoy drop in profit at Rs 56 crore in March 2015 quarter.

Gold, silver turn weak on sluggish demand, global cues

Gold sheds Rs 90 to Rs 26,990 per 10 gm in NCR, Silver loses Rs 100 to Rs 36,900 a kg due on lower offtake by industrial units and coin makers

IDBI Bank rallies on heavy volumes

The stock rallied 8% to Rs 85 on the NSE on back of an over three-fold jump in trading volumes.

 

Back to Top